Compare NICE & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NICE | GRFS |
|---|---|---|
| Founded | 1986 | 1940 |
| Country | Israel | Spain |
| Employees | 9626 | 25247 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.2B |
| IPO Year | N/A | N/A |
| Metric | NICE | GRFS |
|---|---|---|
| Price | $101.79 | $8.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $153.46 | $10.15 |
| AVG Volume (30 Days) | ★ 622.2K | 588.7K |
| Earning Date | 05-14-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.14 | $4.49 |
| Revenue Next Year | $9.62 | $6.42 |
| P/E Ratio | ★ $11.21 | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $83.10 | $6.96 |
| 52 Week High | $153.62 | $10.84 |
| Indicator | NICE | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 55.76 | 59.06 |
| Support Level | $96.49 | $7.45 |
| Resistance Level | $106.36 | $8.36 |
| Average True Range (ATR) | 4.39 | 0.20 |
| MACD | 0.23 | 0.02 |
| Stochastic Oscillator | 80.36 | 63.53 |
Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.